Factors affecting the tissue binding of nicotine in various species

Promoting New Approach Methodologies (NAMs) for research on skin color changes in response to environmental stress factors: tobacco and air pollution

Aging is one of the most dynamic biological processes in the human body and is known to carry significant impacts on individuals' self-esteem. Skin pigmentation is a highly heritable trait made possible by complex, strictly controlled cellular and molecular mechanisms. Genetic, environmental and endocrine factors contribute to the modulation of melanin's amount, type and distribution in the skin layers. One of the hallmarks of extrinsic skin aging induced by environmental stress factors is the alteration of the constitutive pigmentation pattern clinically defined as senile lentigines and/or melasma or other pigmentary dyschromias. The complexity of pollutants and tobacco smoke as environmental stress factors warrants a thorough understanding of the mechanisms by which they impact skin pigmentation through repeated and long-term exposure. Pre-clinical and clinical studies demonstrated that pollutants are known to induce reactive oxygen species (ROS) or inflammatory events that lead directly or indirectly to skin hyperpigmentation. Another mechanistic direction is provided by Aryl hydrocarbon Receptors (AhR) which were shown to mediate processes leading to skin hyperpigmentation in response to pollutants by regulation of melanogenic enzymes and transcription factors involved in melanin biosynthesis pathway. In this context, we will discuss a diverse range of New Approach Methodologies (NAMs) capable to provide mechanistic insights of the cellular and molecular pathways involved in the action of environmental stress factors on skin pigmentation and to support the design of raw ingredients and formulations intended to counter their impact and of any subsequently needed clinical studies.

Simultaneous quantification of tobacco alkaloids and major phase I metabolites by LC-MS/MS in human tissue

INTRODUCTION

Insurance agencies might request laboratories to differentiate whether a deceased has been a smoker or not to decide about refunding of his nonsmoker rate. In this context, the question on a solid proof of tobacco alkaloids and major metabolites in tissues came up. Currently, an appropriate assay is still lacking to analyze tissue distribution in smokers or nonsmokers. Nicotine (NIC), nornicotine (NNIC), anatabine (ATB), anabasine (ABS), and myosmine (MYO) are naturally occurring alkaloids of the tobacco plant; most important phase I metabolites of NIC are cotinine (COT), norcotinine (NCOT), trans-3'-hydroxycotinine (HCOT), nicotine-N'-oxide (NNO), and cotinine-N-oxide (CNO). An analytical assay for their determination was developed and applied to five randomly selected autopsy cases.

METHODS

Homogenates using 500 mg aliquots of tissue samples were analyzed by liquid chromatography/tandem mass spectrometry following solid phase extraction. The method was validated according to current international guidelines.

RESULTS

NIC, COT, NCOT, ABS, ATB, and HCOT could be detected in all tissues under investigation. Highest NIC concentrations were observed in the lungs, whereas highest COT concentrations have been found in the liver. MYO was not detectable in any of the tissues under investigation.

CONCLUSIONS

The assay is able to adequately separate isobaric analyte pairs such as NIC/ABS/NCOT and HCOT/CNO thus being suitable for the determination of tobacco alkaloids and their phase I metabolites from tissue. More autopsy cases as well as corresponding body fluids and hair samples will be investigated to differentiate smokers from nonsmokers.

Cigarette smoke inhibits oocyte cumulus complex pick-up by the oviduct in vitro independent of ciliary beat frequency

The purpose of this study was to quantify the effects of acute exposure to mainstream (MS) and sidestream (SS) smoke solutions on oocyte cumulus complex pick-up rate in explants of hamster oviducts using a newly developed in vitro assay. Experiments were performed in handmade perfusion chambers using infundibula from hamster oviducts and oocyte cumulus complexes harvested from mature ovarian follicles. Oocyte cumulus complex pick-up rate was measured by placing a stained oocyte cumulus complex at the base of the infundibulum and recording the length of time needed for the complex to traverse a defined path to the ostium. Addition of either whole MS or SS smoke solutions to the perfusion chamber caused a dose dependent decrease in oocyte cumulus complex pick-up rate. Unexpectedly, upon washout of smoke solutions with control medium, oocyte cumulus complex pick-up rate continued to decline. The gas phase of MS smoke is more inhibitory than the particulate phase, while SS gas and particulate phases inhibit oocyte cumulus complex pick-up rate at equivalent doses. Ciliary beat frequency and oocyte cumulus complex pick-up rate were measured using the same infundibular explants to determine if smoke solutions decrease oocyte cumulus complex pick-up rate by inhibiting ciliary beat frequency. Ciliary beat frequency decreased in MS smoke solutions and recovered either partially or completely after washout of the smoke solutions. SS smoke solutions either produced no change in ciliary beat frequency or stimulated ciliary beat frequency. Oocyte cumulus complex pick-up rate decreased in both MS and SS smoke solutions and further declined during washout when ciliary beat frequency was equivalent to or higher than controls. These data show that oocyte cumulus complex pick-up rate and ciliary beat frequency can be uncoupled and that smoke solutions inhibit oocyte cumulus complex pick-up rate by affecting factors in addition to ciliary beat frequency. Possible reasons for the smoke induced decrease in oocyte cumulus complex pick-up rate are discussed. These results may explain the increased incidence of tubal infertility and ectopic pregnancy observed in women who smoke.

A physiologically based pharmacokinetic model for nicotine disposition in the Sprague-Dawley rat

A physiologically based pharmacokinetic (PBPK) model was developed to describe the disposition of nicotine in the Sprague-Dawley (SD) rat. Parameters for the model were either obtained from the literature (blood flows, organ volumes) or determined experimentally (partition coefficients). Nicotine metabolism was defined in the liver compartment by the first-order rate constants KNC and KNP which control the rate of nicotine metabolism to cotinine and "polar metabolites" (PM), respectively. These rate constants were estimated by optimizing the model fit to pharmacokinetic data obtained by administering an intraarterial (S)-[5-3H]nicotine bolus of 0.1 mg/kg to 6 rats. Model simulations that optimized for the appearance of cotinine in plasma estimated KNC and KNP to be 75.8 and 24.3 hr-1, respectively. Use of these constants in the model allowed us to accurately predict nicotine plasma kinetics and the fraction of the dose eliminated by renal (8.5%) and metabolic (91.5%) clearance. To validate the model's ability to predict tissue kinetics of nicotine, 21 male SD rats were administered 0.1 mg/kg (S)-[5-3H]nicotine intraarterially. At seven time points following treatment, 3 rats were euthanized and tissues were removed and analyzed for nicotine. Model-predicted nicotine tissue kinetics were in agreement with those determined experimentally in muscle, liver, skin, fat, and kidney. The brain, heart, and lung exhibited nonlinear nicotine elimination, suggesting that saturable nicotinic binding sites may be important in nicotine disposition in these organs. Inclusion of saturable receptor binding expressions in the mathematical description of these compartments resulted in better agreement with the experimental data. The Bmax and KD estimated by model simulations for these tissues were brain, 0.009 and 0.12; lung, 0.039 and 2.0; and heart, 0.039 nmol/tissue and 0.12 nM, respectively. This PBPK model can successfully describe the tissue and plasma kinetics of nicotine in the SD rat and will be a useful tool for pharmacologic studies in humans and experimental animals that require insight into the plasma or tissue concentration-effect relationship.

Oral administration of nicotine: its uptake and distribution after chronic administration to mice

An investigation was made of the suitability of administering nicotine to experimental animals by inclusion in the drinking water. It was found that, after an initial accommodation period of several weeks, nicotine could be administered up to a concentration of 100 micrograms/ml with no decrease in fluid intake or weight gain compared to control. An analysis of the steady-state plasma levels and distribution of nicotine was made in mice which had received nicotine in the drinking water at a concentration of 60 micrograms/ml. The average daily dose of nicotine received by these animals was 17.2 mg/kg. The steady-state plasma level of nicotine was 34.4 ng/ml, representing 6% of the total compound present at steady-state as determined by thin-layer chromatography. The distribution of nicotine or metabolite in mice which had received [methyl-14C]-nicotine orally was determined. Whole-body autoradiography, as well as direct tissue counting, demonstrated that nicotine accumulates in a number of areas, particularly the salivary gland, nasal epithelium, uterus, and liver. There was relatively little material in the blood or brain. This investigation indicates that ad libitum oral administration is an acceptable method for maintaining experimental animals on nicotine for long periods of time.

Cerebral uptake of nicotine and of amino acids

Nicotine is among the compounds that enter the brain very rapidly (blood-flow-limited). It also leaves the brain rapidly; by five minutes, 90% exits, an exit somewhat slower than that of water. In spite of rapid exit, brain levels remain higher than levels in blood over a wide range of blood concentrations. Nicotine enters the fetal circulation from the maternal blood; it enters fetal brain but to a smaller extent than adult brain. Nicotine entry is different from that of amino acid: No interaction of amino acid transport and nicotine could be detected. Most close analogs have no effect on nicotine uptake, but at higher concentrations nicotine uptake is saturable. Nicotine and morphine mutually inhibit each other's uptake. The results suggest an uptake compartment (lipid space) for nicotine shared by morphine.